Events | 2019.03.28
Orion Biotechnology to Present OB-002 in Vitro Potency Data at the 10th International AIDS Society HIV Science Meeting in Mexico City in July 2019
OTTAWA, Ontario, March 28, 2019 /PRNewswire/ -- Orion Biotechnology Canada Ltd., today announced that it will be presenting data on the potency of OB-002, their CCR5 antagonist currently in development for HIV prevention and oncology indications, at the 10th IAS HIV Science Meeting that...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ty-in-july-2019-300820527.html
Follow us on
Instagram is adding automatic in-app text translation - The Verge views: 1520
Here’s a ‘Brand-New’ Massive Multilingual Dataset for Machine Translation views: 1504